US 10385136
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10385136 (Use of semaphorin-4D binding molecules for treating neurodegenerative disorders) held by VACCINEX, INC. expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P